# In silico design of novel recombinant antigens containing immunologically relevant regions of wild-type and escape mutant variants of HBsAg

**Authors:** Yeshwas Abite Workneh, Desye Melese Sisay, Abebaw Fekadu, Abraham Tesfaye Bika, Alemu Tekewe Mogus, Tesfaye Sisay Tessema, Anoop Kumar, Anoop Kumar, Anoop Kumar, Anoop Kumar, Anoop Kumar, Anoop Kumar

PMC · DOI: 10.1371/journal.pone.0344362 · PLOS One · 2026-03-09

## TL;DR

Researchers designed new recombinant antigens combining wild-type and escape mutant HBsAg sequences to improve diagnostic accuracy for hepatitis B.

## Contribution

The study introduces novel recombinant HBsAg antigens combining wild-type and escape mutant sequences for improved immunological detection.

## Key findings

- Three recombinant antigens (MeRPYS1, MeRPYS2, MeRPYS3) were computationally designed using wild-type and escape mutant HBsAg sequences.
- Molecular docking and MD simulations suggest potential stability and interaction patterns of the designed antigens with anti-HBsAg antibodies.

## Abstract

Hepatitis B virus (HBV) contributes substantially to liver cancer, related mortality, and liver transplantation worldwide. The small hepatitis B surface antigen (HBsAg), particularly its major hydrophilic region (MHR) and the “a” determinant, is the primary target of serological diagnostics. However, escape mutant amino acid variants (EMAVs) within this region may reduce diagnostic specificity and sensitivity. In this study, publicly available HBsAg sequences were analyzed to determine the prevalence of EMAVs circulating in Ethiopia. We computationally designed three region-specific recombinant antigens (MeRPYS1, MeRPYS2, and MeRPYS3) by incorporating both wild-type and prevalent EMAV sequences. Linear and conformational B-cell epitopes, as well as T helper cell epitopes, were predicted for each antigen. Homology analyses were also performed to assess similarity to host proteins. Secondary and tertiary structures of the antigens were predicted to generate theoretical molecular models. Molecular docking analyses were performed to explore putative interaction patterns between each designed antigen and an anti-HBsAg-specific antibody. The predicted antigen–antibody complexes were further examined using molecular dynamics (MD) simulations to assess their theoretical stability and behavior over time. The resulting simulations provide predictive computational insights into possible antigenic features and interaction tendencies of the designed constructs. These findings are intended to generate testable hypotheses and should be interpreted cautiously, as the study is limited to in silico analyses and requires experimental validation.

## Linked entities

- **Diseases:** Hepatitis B (MONDO:0005344), liver cancer (MONDO:0002691)

## Full-text entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, LINC01194 (long intergenic non-protein coding RNA 1194) [NCBI Gene 404663] {aka CT49, TAG}, H2 (histocompatibility-2, MHC) [NCBI Gene 111364] {aka H-2, MHC-II}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}
- **Diseases:** liver damage (MESH:D056486), deaths (MESH:D003643), Viral hepatitis (MESH:D014777), EMAVs (MESH:D000592), tuberculosis (MESH:D014376), MHR (MESH:D004830), cirrhosis (MESH:D005355), acute and chronic hepatitis (MESH:D065290), HBV infection (MESH:D006509), HIV (MESH:D015658), infections (MESH:D007239), liver cancer (MESH:D006528)
- **Chemicals:** acid (MESH:D000143), EMAV (-), L (MESH:D007930), water (MESH:D014867), NaCl (MESH:D012965), His (MESH:D006639), amino acid (MESH:D000596), Hydrogen (MESH:D006859)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Musculus (genus) [taxon 112137], Human papillomavirus (species) [taxon 10566], Homo sapiens (human, species) [taxon 9606], Hepatitis B virus (no rank) [taxon 10407], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** P127T, glycine-serine, S143L, Y134F, I110L, S143T, Y134N, A through I, A128V

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12970925/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12970925/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12970925/full.md

---
Source: https://tomesphere.com/paper/PMC12970925